CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
RHLD
Resolute Holdings Management, Inc.
There isn't enough reported data to score RHLD yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
RHLD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Stable | |
| Weak |
RHLD's profitability is currently healthy, and its cash flow is stable, but its balance sheet is weak. There isn't enough data to rate its revenue.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
RHLD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $83.00 | -47% |
| Fair | 21x | $101 | -35% |
| Expensive | 24x | $114 | -27% |
| Current | 33x | $156 | — |
Historical ranges are pointers, not guarantees.
RHLD has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
RHLD Forward outlook
There aren't enough analyst estimates for RHLD to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over RHLD in the latest year-over-year earnings comparison.
RHLD Earnings Per Share
RHLD has returned to profit: it earned $4.72 per share over the past year, after losing money the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
RHLD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $509.6M | +322% |
| Q2 2026 | $473.2M | +296% |
| Q1 2026 | $407.8M | +293% |
| Q3 2025 | $120.9M | +13% |
| Q2 2025 | $119.6M | +10% |
| Q1 2025 | $103.9M | -0.1% |
| Q3 2024 | $107.1M | +11% |
| Q2 2024 | $108.6M | +10% |
RHLD has the edge over CAT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -11 points |
| Q2 2026 | 7.4% | -27 points |
| Q1 2026 | -1.4% | -26 points |
| Q4 2025 | 30% | N/A |
| Q3 2025 | 34% | +3.6 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 25% | -6.5 points |
| Q3 2024 | 31% | -0.6 points |
RHLD has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
RHLD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $94.3M | +61% |
| Q2 2026 | $81.3M | +71% |
| Q1 2026 | -$124.2M | -798% |
| Q4 2025 | $65.3M | +$65.8M |
| Q3 2025 | $58.6M | +69% |
| Q2 2025 | $47.5M | +39% |
| Q1 2025 | $17.8M | -48% |
| Q4 2024 | -$497.8K | -102% |
RHLD has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
RHLD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.5% | -284K shares |
| 1 year | -8.3% | -706K shares |
| 3 years | -7.9% | -667K shares |
RHLD has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.4M |
| Q2 2026 | $49.5M |
| Q1 2026 | $38M |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over RHLD on leverage, with a lower net debt burden relative to earnings.
RHLD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.2x | High |
| Q2 2026 | 13.9x | High |
| Q1 2026 | 15.3x | High |
| Q4 2025 | 0.2x | Very low |
| Q3 2024 | 2.4x | Moderate |
| Q2 2024 | 2.6x | Moderate |
| Q1 2024 | -0.3x | Net Cash |
RHLD's net debt is about 8.2 years of its operating earnings (EBITDA), up from 2.4 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RHLD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.7 | Neutral |
| Stochastic | 67.1 | Neutral |
RHLD's weekly RSI is 61 (neutral) and its Stochastic is 67 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over RHLD on valuation relative to its sector.
RHLD PE vs Industrials Sector
| Metric | RHLD | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 24x | 37% above |
| PE % | 100 | 27 | 73 pts above |
RHLD is trading at 33x earnings, a 37% premium to the Industrials sector's median of 24x, though its earnings don't support one.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
RHLD has stronger trend alignment. CAT is above 2 of 5 weekly averages versus RHLD above 3 of 3.
RHLD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $127.9 | 22% above |
| 20 week MA | $130.7 | 19% above |
| 50 week MA | $149.3 | 4.4% above |
RHLD is in an uptrend: it's above all three of its weekly moving averages, and 4.4% above its 50-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over RHLD on returns for 2026, with the stronger performance.
RHLD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $46.8 | $217.4 | +364% |
| 2026 YTD | $217.4 | $156.0 | -28% |
RHLD has finished every year since 2025 higher, and it's down 28% so far in 2026.